Breast conserving surgery for invasive breast cancer: Risk factors for ipsilateral breast tumor recurrences

Breast Cancer Research and Treatment

Volumn 43, Issue 1, 1997, Pages 73-86

  Dalberg, K ^a   Mattsson, A ^a   Rutqvist, L E ^a   Johansson, U ^a   Riddez, L ^b   Sandelin, K ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b STOCKHOLM SÖDER HOSPITAL   (Sweden)

Author keywords

Breast cancer; Ipsilateral breast tumor recurrence; Partial mastectomy; Radiotherapy; Risk factors

Indexed keywords

CYCLOPHOSPHAMIDE; FLUOROURACIL; METHOTREXATE; TAMOXIFEN;

ADULT; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER RECURRENCE; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PARTIAL MASTECTOMY; POSTOPERATIVE CARE; PREMENOPAUSE; PRIORITY JOURNAL; RECURRENCE RISK; STATISTICAL ANALYSIS; TUMOR VOLUME;

EID: 0031048355     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005732224717     Document Type: Article

References (54)

1. Fisher B, Anderson S, Redmond C, Wolmark N, Wickerham L, Cronin W: Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. New Engl J Med 333: 1456-1461
2. Veronesi U, Banfi A, Salvadori B, Luini A, Saccozzi S, Zucali R, Marubini E, Del Vecchio M, Boracchi P, Marchini S, Merson M, Sacchini V, Riboldi G, Santoro G: Breast conservation is the treatment of choice in small breast cancer: long-term results of a randomized trial. Eur J Cancer 26(6): 668-670, 1990
3. Conference NC: Treatment of early-stage breast cancer. JAMA 265: 391-397, 1991
4. Omne-Ponten M, Holmberg L, Sjödén P-O: Psychosocial adjustment among women with breast cancer stages I and II: a 6 year follow-up of consecutive patients. Comprehensive summaries of Uppsala Dissertations from the Faculty of Medicine 1993, 425
5. Omne-Pontén M, Holmberg M, Burns T: Determinants of the psychosocial outcome after operation for breast cancer. Results of a prospective comparative interview study following mastectomy and breast conservation. Eur J Cancer 28A: 1062-1067, 1992
6. Bartelink H, van Dam F, van Dongen J: Psychological effects of breast conserving therapy in comparison with radical mastectomy. Int J Radiat Oncol Biol Phys 11: 381-385, 1985
7. Clark RM, McCullogh PB, Levine MN, Lipa M, Wilkinson RH, Mahoney LJ, Basrur VR, Nair BD, McDermot RS, Wong CS, Corbett PJ: Randomized clinical trial to assess the effectiveness of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer. J Natl Cancer Inst 84: 683-689, 1992
8. Veronesi U, Volerrani F, Luini A, Saccozzi R, Del Vecchio M, Zucali R, Galimberti V, Rasponi A, De Re E, Squicciarini P, Salvadori B: Quadrantectomy versus lumpectomy for small size breast cancer. Eur J Cancer 26(6): 671-673, 1990
9. Liljegren G, Holmberg L, Adami HO: Sector resection with or without postoperative radiotherapy for stage I breast cancer: five-year results of a randomized trial. J Natl Cancer Inst 86: 717-722, 1994
10. Veronesi U, Luini A, Del Vecchio M, Greco M, Galimberti V, Merson M, Rilke F, Sacchini V, Saccozzi R, Savio T, Zucali R, Zurrida S, Salvadori B: Radiotherapy after breast-preserving surgery in women with localized cancer of the breast. New Engl J Med 328(22): 1587-1591, 1993
11. Kurtz JM, Amalric R, Brandone H, Ayme Y, Jacquemier J, Pietra JC, Hans D, Pollet JF, Bressac C, Spitalier JM: Local recurrence after breast-conserving surgery and radiotherapy. Cancer 63: 1912-1917, 1989
12. Borger J, Kemperman H, Hart A, Peterse H, van Dongen J, Bartelink H: Risk factors in breast-conserving therapy. J Clin Oncol 12(4): 653-660, 1994
13. Clarke DH, Lê MG, Sarrazin D, Lacombe MJ, Fontaine F, Travagli JP, May-Levin F, Contesso G, Arriagada R: Analysis of local-regional relapses in patients with early breast cancers treated by excision and radiotherapy: experience of the Institute Gustave-Roussy. Int J Radial Oncol Biol Phys 11: 137-145, 1985
14. Fowble BL, Solin LJ, Schultz DJ, Goodman RL: Ten year results of conservative surgery and irradiation for stage I and II breast cancer. Int J Radiat Oncol Biol Phys 21: 269-277, 1991
15. Stotter A, Atkinson EN, Fairston BA, McNeese M, Oswald MJ, Balch CM: Survival following locoregional recurrence after breast conservation therapy for cancer. Ann Surg 212 (2): 166-172, 1990
16. de la Rochefordiere A, Asselain B, Campana F, Scholl SM, Fenton J, Vilcoq JR, Durand JC, Pouillart P, Magdelenat H, Fourquet A: Age as prognostic factor in premenopausal breast carcinoma. Lancet 341:1039-1042, 1993
17. Boyages J, Recht A, Connolly JL, Schnitt SJ, Felman R, Dooy H, Love S, Osteen RT, Candy B, Silver B, Harris JR: Early breast cancer: predictors of breast recurrence for patients treated with conservative surgery and radiation therapy. Radiotherapy Oncol 19: 29-41, 1990
18. Bartelink H, Borger JH, van Dongen JA, Peterse JL: The impact of tumor size and histology on local control after breast-conserving therapy. Radiotherapy Oncol 11:297-303, 1988
19. Kurtz JM, Jacquemier J, Amalric R, Brandone H, Ayme Y, Hans D, Bressac C, Roth J, Spitalier JM: Risk factors for breast recurrence in premenopausal and postmenopausal patients with ductal cancers treated by conservation therapy. Cancer 65:1867-1878, 1990
20. Kurtz JM: Factors influencing the risk of local recurrence in the breast. Eur J Cancer 28(2/3): 660-666, 1992
21. Recht A, Connolly JL, Schnitt SJ, Silver B, Rose MA, Love S, Harris JR: The effect of young age on tumor recurrence in the treated breast after conservative surgery and radiotherapy. Int J Radiat Oncol Biol Phys 14: 3-10, 1988
22. Haffty BG, Fischer D, Rose M, Beinfield M, McKhann C: Prognostic factors for local recurrence in the conservatively treated breast cancer patients: a cautious interpretation of the data. J Clin Oncol 9(6): 997-1003, 1991
23. Ghossein NA, Alpert S, Barba J, Pressman P, Stacey P, Lorenz E, Shulman M, Sadarangani GJ: Breast cancer. Importance of adequate surgical excision prior to radiotherapy in the local control of breast cancer in patients treated conservatively. Arch Surg 127: 411-415, 1992
24. Harris JR, Connolly JL, Schnitt SJ, Cohen RB, Hellman S: Clinical-pathologic study of early breast cancer treated by primary radiation therapy. J Clin Oncol 1(3): 184-189, 1983
25. Vicini FA, Recht A, Abner A, Boyages J, Cady B, Connolly JL, Gelman R, Osteen RT, Schnitt SJ, Silen W, Harris JR: Recurrence in the breast following conservative surgery and radiation therapy for early-stage breast cancer. J Natl Cancer Inst Monographs 11: 33-39, 1992
26. Pezner RD, Wagman LD, Ben-Ezra J, Odom-Maryon T: Breast conservation therapy: local tumor control in patients with pathologically clear margins who receive 5000 cGy breast irradiation without local boost. Breast Cancer Res Treat 32: 261-267, 1994
27. Fisher B, Anderson S, Fisher ER, Redmond C, Wickerham DI, Wolmark N, Mamounas EP, Deutsch M, Margolese R: Significance of ipsilateral breast tumour recurrence after lumpectomy. Lancet 338(8763): 327-331, 1991
28. Whelan T, Clark R, Roberts R, Levine M, Foster G, Group I.o.t.O.C.O.: Ipsilateral breast tumor recurrence postlumpectomy is predictive of subsequent mortality: results from a randomized trial. Int J Radiat Oncol Biol Phys 30(1): 11-16, 1994
29. Kattlove H, Liberati A, Keeler E, Brook RH: Benefits and costs of screening and treatment for early breast cancer. JAMA 11(2): 142-154, 1995
30. Cedermark B, Askergren J, Alveryd A, Glas U, Kvarnström L, Somell A, Theve NO, Wallgren A: Breast-conserving treatment for breast cancer in Stockholm, Sweden, 1977 to 1981. Cancer 53(6): 1253-1255, 1984
31. Wrange Ö, Nordenskjöld B, Gustafsson JÅ: Cytosol estradiol receptor in human mammary carcinoma: an assay based on isoelectric focusing in polyacrylamide gel. Anal Biochem 85(2): 461-475, 1978
32. Wrange Ö, Humla S, Ramberg I, Gustafsson S, Nordenskjöld B, Gustafsson JÅ: Progestin-receptor analysis in human breast cancer cylosol by isoelectric focusing in slabs of polyacrylamide gel. J Ster Biochem 14: 141-148, 1981
33. Rutqvist LE, Cedermark B, Glas LJ, Mattson A, Skoog L, Somell A, Theve T, Wilking N, Askergren J, Hjalmar M, Rotstein S, Perbeck L, Ringborg U: Contralateral primary tumors in breast cancer patients in a randomized trial of adjuvant tamoxifen therapy. J Natl Cancer Inst 18: 1299-1307, 1991
34. Clayton D, Hills M: Statistical models in epidemiology. Oxford Science Publications. Oxford University Press 1993
35. Preston DL, Lubin JH, Pierce DA, McConney ME: EPI-CURE: User's guide & command summary. Hirosoft International Corp: Seattle 1988-1993
36. Coleman MP, Hermon C, Douglas A: Person-years (PYRS). A fortran program for cohort study analysis. IARC International Report No 89/006. International Agency for Research on Cancer. World Health Organi/ation: Lyon 1989
37. Valagussa P, Bonadonna G, Veronesi U: Patterns of relapse and survival following radical mastectomy: analysis of 716 consecutive patients. Cancer 41: 1170-1178, 1978
38. Fisher ER, Sass R, Fisher B, Gregorio R, Brown R, Wickerham L, et al.: Pathologic findings from the National Surgical Adjuvant Breast Project (protocol 6). Cancer 57: 1717-1724, 1986
39. Stotter AT, McNeese MD, Ames FC, Oswals MJ, Ellerbroek NA: Predicting the rate and extent of locoregional failure after breast conservation therapy for early breast cancer. Cancer 64: 2217-2225, 1989
40. Recht A, Schnitt SJ, Connolly JL, Gelman RS, Rose MA, Silver B, Harris JR: Time course of local recurrence following conservative surgery and radiotherapy for early stage breast cancer. Int J Radiat Oncol Biol Phys 15:255-261, 1988
41. Mattsson A, Rudén B-I, Hall P, Wilking N, Rutqvist LE: Radiation-induced breast cancer: long-term follow-up of radiation therapy for benign breast disease. J Natl Cancer Inst 85(20): 1679-1685, 1993
42. Shore RE, Hildreth N, Woodard E, Dvoretsky P, Hempelmann L, Pasternack B: Breast cancer among women given X-ray therapy for acute postpartum mastitis. J Natl Cancer Inst 77(3): 689-696, 1986
43. Pizzarello DJ, Roses DF, Newall J, Barish RJ: The carcinogenicity of radiation therapy. Surg Gynecol Obstet 159: 189-200, 1984
44. Solin LJ, Fowble B, Schultz DJ, Goodman RL: Age as a prognostic factor for patients treated with definitive irradiation for early stage breast cancer. Int J Radiat Oncol Biol Phys 16: 373-381, 1989
45. Mate TP, Carter D, Fischer DB, Hartman PV, McKhann C, Merino M, Prosnitz LR, Weissberg JB: A clinical and histopathologic analysis of the results of conservation surgery and radiation therapy in stage I and II breast carcinoma. Cancer 58: 1995-2002, 1986
46. van Dongen JA, Bartelink H, Fentiman IS, Lerut T, Mignolet F, Olthuis G, van der Schueren E, Sylvester R, Tong D, Winter J, van Zijl K: Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer: EORTC trial 10801, breast conservation compared with mastectomy in TNM stage I and II breast cancer. Eur J Cancer 28A(4/5): 801-805, 1992
47. Donegan WL, Perez-Mesa CM, Watson FR: A biostatistical study of locally recurrent breast carcinoma. Surg Gynecol Obstet 122: 529-540, 1966
48. Recht A, Schnitt SJ, Connolly JL, Rose MA, Silver B, Come S, Henderson C, Slavin S, Harris JR: Prognosis following local or regional recurrence after conservative surgery and radiotherapy for early stage breast carcinoma. Int J Radiat Oncol Biol Phys 16: 3-9, 1989
49. Kurtz JM, Jacquemier J, Torhorst J, Spitalier JM, Amalric R, Hünig R, Walther E, Harder F, Almendral A, Brandone H, Ayme Y, Roth J: Conservation therapy for breast cancers other than infiltrating ductal carcinoma. Cancer 63: 1630-1635, 1989
50. Solin LJ, Fowble BL, Schultz DJ, Goodman RL: The significance of the pathology margins of the tumor excision on the outcome of patients treated with definitive radiation for early stage breast cancer. Int J Radiat Oncol Biol Phys 21: 279-287, 1991
51. Nolvadex Adjuvant Trial Organization: Analysis at eight years by Nolvadex Adjuvant Trial Organization: controlled trial of lamoxiten as a single adjuvant agent in the management of early breast cancer. Br J Cancer 57: 608-611, 1988
52. Scottish Cancer Trials Office: Adjuvant tamoxifen in the management of operable breast cancer: the Scottish trial. Lancet 2: 171-174, 1987
53. Nakamura Y, Tominaga T, Nomura Y, Kuyama H, Miura S, Morimoto T: A randomized clinical trial of adjuvant endocrine therapy after breast conserving surgery for early breast cancer. Cooperative Study Group for Breast Conserving Therapy. Gan To Kagaku Ryoho 21(2): 217-225, 1994
54. Fisher B, Constantino J, Redmond C, et al.: A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen receptor-positive tumors. N Engl J Med 320: 479-484, 1989